| Year |
Citation |
Score |
| 2024 |
Pillai R, LeBoeuf SE, Hao Y, New C, Blum JLE, Rashidfarrokhi A, Huang SM, Bahamon C, Wu WL, Karadal-Ferrena B, Herrera A, Ivanova E, Cross M, Bossowski JP, Ding H, ... ... Poirier JT, et al. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in mutant lung cancer. Science Advances. 10: eadm9859. PMID 38536921 DOI: 10.1126/sciadv.adm9859 |
0.605 |
|
| 2024 |
Tendler S, Dunphy MP, Agee M, O'Donoghue J, Aly RG, Choudhury NJ, Kesner A, Kirov A, Mauguen A, Baine MK, Schoder H, Weber WA, Rekhtman N, Lyashchenko SK, Bodei L, ... ... Poirier JT, et al. First-in-human imaging with [Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. Medrxiv : the Preprint Server For Health Sciences. PMID 38260492 DOI: 10.1101/2024.01.10.24301109 |
0.584 |
|
| 2023 |
Zavitsanou AM, Pillai R, Hao Y, Wu WL, Bartnicki E, Karakousi T, Rajalingam S, Herrera A, Karatza A, Rashidfarrokhi A, Solis S, Ciampricotti M, Yeaton AH, Ivanova E, Wohlhieter CA, ... Poirier JT, et al. KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. Cell Reports. 42: 113295. PMID 37889752 DOI: 10.1016/j.celrep.2023.113295 |
0.57 |
|
| 2023 |
Pillai R, LeBoeuf SE, Hao Y, New C, Blum JLE, Rashidfarrokhi A, Huang SM, Bahamon C, Wu WL, Karadal-Ferrena B, Herrera A, Ivanova E, Cross M, Bossowski JP, Ding H, ... Poirier JT, et al. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in mutant lung cancer. Biorxiv : the Preprint Server For Biology. PMID 37425844 DOI: 10.1101/2023.06.27.546750 |
0.582 |
|
| 2023 |
Rudin CM, Balli D, Lai WV, Richards AL, Nguyen E, Egger JV, Choudhury NJ, Sen T, Chow A, Poirier JT, Geese WJ, Hellmann MD, Forslund A. Clinical benefit from immunotherapy in patients with small cell lung cancer is associated with tumor capacity for antigen presentation. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 37210008 DOI: 10.1016/j.jtho.2023.05.008 |
0.593 |
|
| 2023 |
Deng J, Peng DH, Fenyo D, Yuan H, Lopez A, Levin DS, Meynardie M, Quinteros M, Ranieri M, Sahu S, Lau SCM, Shum E, Velcheti V, Punekar SR, Rekhtman N, ... Poirier JT, et al. metabolomics identifies CD38 as an emergent vulnerability in -mutant lung cancer. Biorxiv : the Preprint Server For Biology. PMID 37131623 DOI: 10.1101/2023.04.18.537350 |
0.521 |
|
| 2022 |
Pan Y, Han H, Hu H, Wang H, Song Y, Hao Y, Tong X, Patel AS, Misirlioglu S, Tang S, Huang HY, Geng K, Chen T, Karatza A, Sherman F, ... ... Poirier JT, et al. KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. Cancer Cell. PMID 36525973 DOI: 10.1016/j.ccell.2022.11.015 |
0.404 |
|
| 2022 |
Offin M, Sauter JL, Tischfield SE, Egger JV, Chavan S, Shah NS, Manoj P, Ventura K, Allaj V, de Stanchina E, Travis W, Ladanyi M, Rimner A, Rusch VW, Adusumilli PS, ... Poirier JT, et al. Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library. Genome Medicine. 14: 127. PMID 36380343 DOI: 10.1186/s13073-022-01129-4 |
0.399 |
|
| 2022 |
Quintanal-Villalonga Á, Chan JM, Masilionis I, Gao VR, Xie Y, Allaj V, Chow A, Poirier JT, Pe'er D, Rudin CM, Mazutis L. Protocol to dissociate, process, and analyze the human lung tissue using single-cell RNA-seq. Star Protocols. 3: 101776. PMID 36313536 DOI: 10.1016/j.xpro.2022.101776 |
0.469 |
|
| 2022 |
Chemi F, Pearce SP, Clipson A, Hill SM, Conway AM, Richardson SA, Kamieniecka K, Caeser R, White DJ, Mohan S, Foy V, Simpson KL, Galvin M, Frese KK, Priest L, ... Poirier JT, et al. cfDNA methylome profiling for detection and subtyping of small cell lung cancers. Nature Cancer. PMID 35941262 DOI: 10.1038/s43018-022-00415-9 |
0.543 |
|
| 2022 |
Korsen JA, Gutierrez JA, Tully KM, Carter LM, Samuels ZV, Khitrov S, Poirier JT, Rudin CM, Chen Y, Morris MJ, Bodei L, Pillarsetty N, Lewis JS. Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 119: e2203820119. PMID 35759660 DOI: 10.1073/pnas.2203820119 |
0.467 |
|
| 2022 |
Caeser R, Egger JV, Chavan S, Socci ND, Jones CB, Kombak FE, Asher M, Roehrl MH, Shah NS, Allaj V, Manoj P, Tischfield SE, Kulick A, Meneses M, Iacobuzio-Donahue CA, ... Poirier JT, et al. Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts. Nature Communications. 13: 2144. PMID 35440124 DOI: 10.1038/s41467-022-29794-4 |
0.594 |
|
| 2022 |
Korsen JA, Kalidindi TM, Khitrov S, Samuels ZV, Chakraborty G, Gutierrez JA, Poirier JT, Rudin CM, Chen Y, Morris MJ, Pillarsetty N, Lewis JS. Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand 3. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35058323 DOI: 10.2967/jnumed.121.263221 |
0.44 |
|
| 2022 |
Tully KM, Tendler S, Carter LM, Sharma SK, Samuels ZV, Mandleywala K, Korsen JA, Delos Reyes AM, Piersigilli A, Travis WD, Sen T, Pillarsetty N, Poirier JT, Rudin CM, Lewis JS. Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer exhibits antitumor efficacy with low toxicity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35046060 DOI: 10.1158/1078-0432.CCR-21-1533 |
0.632 |
|
| 2021 |
Luu AP, Yao Z, Ramachandran S, Azzopardi SA, Miles LA, Schneider WM, Hoffmann HH, Bozzacco L, Garcia G, Gong D, Damoiseaux R, Tang H, Morizono K, Rudin CM, Sun R, ... ... Poirier JT, et al. A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry. Viruses. 13. PMID 34834920 DOI: 10.3390/v13112113 |
0.404 |
|
| 2021 |
Quintanal-Villalonga A, Taniguchi H, Hao Y, Chow A, Zhan YA, Chavan SS, Uddin F, Allaj V, Manoj P, Shah NS, Chan JM, Offin M, Ciampricotti M, Ray-Kirton J, Egger J, ... Poirier JT, et al. Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy. Cancer Research. PMID 34815254 DOI: 10.1158/0008-5472.CAN-21-2964 |
0.636 |
|
| 2021 |
Caeser R, Hulton C, Costa E, Durani V, Little M, Chen X, Tischfield SE, Asher M, Kombak FE, Chavan SS, Shah NS, Ciampricotti M, de Stanchina E, Poirier JT, Rudin CM, et al. MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer. Iscience. 24: 103224. PMID 34712921 DOI: 10.1016/j.isci.2021.103224 |
0.572 |
|
| 2021 |
Chan JM, Quintanal-Villalonga Á, Gao VR, Xie Y, Allaj V, Chaudhary O, Masilionis I, Egger J, Chow A, Walle T, Mattar M, Yarlagadda DVK, Wang JL, Uddin F, Offin M, ... Poirier JT, et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell. PMID 34653364 DOI: 10.1016/j.ccell.2021.09.008 |
0.603 |
|
| 2021 |
Ciampricotti M, Karakousi T, Richards AL, Quintanal-Villalonga A, Karatza A, Caeser R, Costa EA, Allaj V, Manoj P, Spainhower KB, Kombak FE, Sanchez-Rivera FJ, Jaspers JE, Zavitsanou AM, Maddalo D, ... Poirier JT, et al. Rlf-Mycl gene fusion drives tumorigenesis and metastasis in a mouse model of small cell lung cancer. Cancer Discovery. PMID 34344693 DOI: 10.1158/2159-8290.CD-21-0441 |
0.602 |
|
| 2021 |
Quintanal-Villalonga A, Taniguchi H, Zhan YA, Hasan MM, Chavan SS, Meng F, Uddin F, Manoj P, Donoghue MTA, Won HH, Chan JM, Ciampricotti M, Chow A, Offin M, Chang JC, ... ... Poirier JT, et al. Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation. Cancer Discovery. PMID 34155000 DOI: 10.1158/2159-8290.CD-20-1863 |
0.583 |
|
| 2021 |
Deng J, Thennavan A, Dolgalev I, Chen T, Li J, Marzio A, Poirier JT, Peng D, Bulatovic M, Mukhopadhyay S, Silver H, Papadopoulos E, Pyon V, Thakurdin C, Han H, et al. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer. Nature Cancer. 2: 503-514. PMID 34142094 DOI: 10.1038/s43018-021-00208-6 |
0.55 |
|
| 2021 |
Chow A, Schad S, Green MD, Hellmann MD, Allaj V, Ceglia N, Zago G, Shah NS, Sharma SK, Mattar M, Chan J, Rizvi H, Zhong H, Liu C, Bykov Y, ... ... Poirier JT, et al. Tim-4 cavity-resident macrophages impair anti-tumor CD8 T cell immunity. Cancer Cell. PMID 34115989 DOI: 10.1016/j.ccell.2021.05.006 |
0.502 |
|
| 2021 |
Jayawardena N, Miles LA, Burga LN, Rudin C, Wolf M, Poirier JT, Bostina M. N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection. Viruses. 13. PMID 33924774 DOI: 10.3390/v13050769 |
0.428 |
|
| 2021 |
Sharma SK, Adumeau P, Keinänen O, Sisodiya V, Sarvaiya H, Tchelepi R, Korsen JA, Pourat J, Edwards KJ, Ragupathi A, Hamdy O, Saunders LR, Rudin CM, Poirier JT, Lewis JS, et al. Synthesis and Comparative Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET. Bioconjugate Chemistry. PMID 33835770 DOI: 10.1021/acs.bioconjchem.1c00121 |
0.495 |
|
| 2021 |
Cooper J, Xu Q, Zhou L, Pavlovic M, Ojeda V, Moulick K, de Stanchina E, Poirier JT, Zauderer M, Rudin CM, Karajannis MA, Hanemann CO, Giancotti FG. Correction: Combined Inhibition of NEDD8-activating Enzyme and mTOR Suppresses NF2 Loss-driven Tumorigenesis. Molecular Cancer Therapeutics. 20: 450. PMID 33547247 DOI: 10.1158/1535-7163.MCT-20-1027 |
0.363 |
|
| 2020 |
Hulton CH, Costa EA, Shah NS, Quintanal-Villalonga A, Heller G, de Stanchina E, Rudin CM, Poirier JT. Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid functional genomics. Nature Cancer. 1: 359-369. PMID 33345196 DOI: 10.1038/s43018-020-0040-8 |
0.531 |
|
| 2020 |
Hoffmann HH, Schneider WM, Rozen-Gagnon K, Miles LA, Schuster F, Razooky B, Jacobson E, Wu X, Yi S, Rudin CM, MacDonald MR, McMullan LK, Poirier JT, Rice CM. TMEM41B Is a Pan-flavivirus Host Factor. Cell. PMID 33338421 DOI: 10.1016/j.cell.2020.12.005 |
0.363 |
|
| 2020 |
Wohlhieter CA, Richards AL, Uddin F, Hulton CH, Quintanal-Villalonga À, Martin A, de Stanchina E, Bhanot U, Asher M, Shah NS, Hayatt O, Buonocore DJ, Rekhtman N, Shen R, Arbour KC, ... ... Poirier JT, et al. Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer. Cell Reports. 33: 108444. PMID 33264619 DOI: 10.1016/j.celrep.2020.108444 |
0.514 |
|
| 2020 |
Hoffmann HH, Schneider WM, Rozen-Gagnon K, Miles LA, Schuster F, Razooky B, Jacobson E, Wu X, Yi S, Rudin CM, MacDonald MR, McMullan LK, Poirier JT, Rice CM. TMEM41B is a pan-flavivirus host factor. Biorxiv : the Preprint Server For Biology. PMID 33052348 DOI: 10.1101/2020.10.09.334128 |
0.363 |
|
| 2020 |
Baine MK, Hsieh MS, Lai WV, Egger JV, Jungbluth A, Daneshbod Y, Beras A, Spencer R, Lopardo J, Bodd F, Montecalvo J, Sauter JL, Chang JC, Buonocore DJ, Travis WD, ... ... Poirier JT, et al. Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 33011388 DOI: 10.1016/j.jtho.2020.09.009 |
0.529 |
|
| 2020 |
Marjanovic ND, Hofree M, Chan JE, Canner D, Wu K, Trakala M, Hartmann GG, Smith OC, Kim JY, Evans KV, Hudson A, Ashenberg O, Porter CBM, Bejnood A, Subramanian A, ... ... Poirier JT, et al. Emergence of a High-Plasticity Cell State during Lung Cancer Evolution. Cancer Cell. PMID 32707077 DOI: 10.1016/J.Ccell.2020.06.012 |
0.634 |
|
| 2020 |
Li F, Ng WL, Luster TA, Hu H, Sviderskiy VO, Dowling CM, Hollinshead KER, Zouitine P, Zhang H, Huang Q, Ranieri M, Wang W, Fang Z, Chen T, Deng J, ... ... Poirier JT, et al. Epigenetic CRISPR screens identify Npm1 as a therapeutic vulnerability in non-small cell lung cancer. Cancer Research. PMID 32646968 DOI: 10.1158/0008-5472.Can-19-3782 |
0.568 |
|
| 2020 |
Kern JA, Kim J, Foster DG, Mishra R, Gardner EE, Poirier JT, Rivard C, Yu H, Finigan JH, Dowlati A, Rudin CM, Tan AC. Role of mTOR as an essential kinase in SCLC. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32599072 DOI: 10.1016/J.Jtho.2020.05.026 |
0.569 |
|
| 2020 |
Han T, Goswami S, Hu Y, Tang F, Zafra MP, Murphy C, Cao Z, Poirier JT, Khurana E, Elemento O, Hechtman JF, Ganesh K, Yaeger R, Dow LE. Lineage reversion drives WNT independence in intestinal cancer. Cancer Discovery. PMID 32546576 DOI: 10.1158/2159-8290.Cd-19-1536 |
0.345 |
|
| 2020 |
Li BT, Michelini F, Misale S, Cocco E, Baldino L, Cai Y, Shifman S, Tu HY, Myers ML, Xu C, Mattar M, Khodos I, Little M, Qeriqi B, Weitsman G, ... ... Poirier JT, et al. HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers. Cancer Discovery. PMID 32213539 DOI: 10.1158/2159-8290.Cd-20-0215 |
0.635 |
|
| 2020 |
Jayawardena N, Poirier JT, Burga LN, Bostina M. Virus-Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development. Oncolytic Virotherapy. 9: 1-15. PMID 32185149 DOI: 10.2147/OV.S186337 |
0.307 |
|
| 2020 |
Laughney AM, Hu J, Campbell NR, Bakhoum SF, Setty M, Lavallée VP, Xie Y, Masilionis I, Carr AJ, Kottapalli S, Allaj V, Mattar M, Rekhtman N, Xavier JB, Mazutis L, ... Poirier JT, et al. Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nature Medicine. PMID 32042191 DOI: 10.1038/S41591-019-0750-6 |
0.624 |
|
| 2020 |
Poirier JT, George J, Owonikoko TK, Berns A, Brambilla E, Byers LA, Carbone D, Chen HJ, Christensen CL, Dive C, Farago AF, Govindan R, Hann C, Hellmann MD, Horn L, et al. New approaches to small cell lung cancer therapy : from the laboratory to the clinic. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32018053 DOI: 10.1016/J.Jtho.2020.01.016 |
0.664 |
|
| 2020 |
Lai WV, Egger JV, Rizvi H, Richards AL, Beras A, Baine MK, Hsieh M, Chang JC, Rekhtman N, Plodkowski AJ, Ginsberg MS, Kris MG, Hellmann MD, Sen T, Poirier JT, et al. Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer. Journal of Clinical Oncology. 38: 9018-9018. DOI: 10.1200/Jco.2020.38.15_Suppl.9018 |
0.5 |
|
| 2020 |
Ciampricotti M, Karakousi T, Villalonga AQ, Allaj V, Ventura A, Sen T, Poirier J, Papagiannakopoulos T, Rudin CM. Abstract 420: Rlf-Mycl1 gene fusion as a novel oncogenic driver in a mouse model of small cell lung cancer Cancer Research. 80: 420-420. DOI: 10.1158/1538-7445.Am2020-420 |
0.523 |
|
| 2020 |
Chan JE, Marjanovic ND, Hofree M, Canner D, Wu K, Hartmann G, Smith OC, Kim J, Hudson A, Subramanian A, Pitter K, Rekhtman N, Massion PP, Poirier JT, Rudin CM, et al. Abstract 1511: A highly plastic cell state emerges during lung adenocarcinoma evolution Tumor Biology. DOI: 10.1158/1538-7445.Am2020-1511 |
0.433 |
|
| 2020 |
Chow A, Schad S, Green M, Hellmann M, Ceglia N, Allaj V, Zago G, Shah N, Sharma S, Mattar M, Chan J, Rizvi H, Zhong H, Liu C, Bykov Y, ... ... Poirier J, et al. 524 Tim-4+ resident macrophages impair anti-tumor immunity in the serous body cavities By sequestering viable and cytotoxic CD8+ T cells expressing high levels of phosphatidylserine Journal For Immunotherapy of Cancer. 8: A560-A560. DOI: 10.1136/jitc-2020-sitc2020.0524 |
0.312 |
|
| 2020 |
Hulton CH, Costa EA, Shah NS, Quintanal-Villalonga A, Heller G, de Stanchina E, Rudin CM, Poirier JT. Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics Nature Cancer. 1: 359-369. DOI: 10.1038/S43018-020-0040-8 |
0.573 |
|
| 2020 |
Poirier J. IA24 Targeting DLL3 in Small-Cell Lung Cancer with Novel Modalities Journal of Thoracic Oncology. 15: S8. DOI: 10.1016/j.jtho.2019.12.024 |
0.471 |
|
| 2019 |
Dammert MA, Brägelmann J, Olsen RR, Böhm S, Monhasery N, Whitney CP, Chalishazar MD, Tumbrink HL, Guthrie MR, Klein S, Ireland AS, Ryan J, Schmitt A, Marx A, Ozretić L, ... ... Poirier JT, et al. MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer. Nature Communications. 10: 3485. PMID 31375684 DOI: 10.1038/S41467-019-11371-X |
0.52 |
|
| 2019 |
Laddha SV, da Silva EM, Robzyk K, Untch BR, Ke H, Rekhtman N, Poirier JT, Travis WD, Tang LH, Chan CS. Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids. Cancer Research. PMID 31300474 DOI: 10.1158/0008-5472.Can-19-0214 |
0.432 |
|
| 2019 |
Devarakonda S, Sankararaman S, Herzog B, Gold KA, Waqar SN, Ward JP, Raymond VM, Lanman RB, Chaudhuri AA, Owonikoko TK, Li BT, Poirier JT, Rudin CM, Govindan R, Morgensztern D. Circulating Tumor DNA Profiling in Small Cell Lung Cancer Identifies Potentially Targetable Alterations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31300452 DOI: 10.1158/1078-0432.Ccr-19-0879 |
0.6 |
|
| 2019 |
Laird J, Lok BH, Carney B, Kossatz S, de Stanchina E, Reiner T, Poirier JT, Rudin CM. PET Imaging of a [F]-radiolabeled PARP Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in Small Cell Lung Cancer Patient-Derived Xenografts. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31195178 DOI: 10.1016/J.Jtho.2019.05.032 |
0.62 |
|
| 2019 |
Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, Heymach JV, Johnson JE, Lehman JM, MacPherson D, Massion PP, Minna JD, Oliver TG, Quaranta V, Sage J, et al. Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nature Reviews. Cancer. PMID 31175338 DOI: 10.1038/S41568-019-0164-2 |
0.608 |
|
| 2019 |
Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, Heymach JV, Johnson JE, Lehman JM, MacPherson D, Massion PP, Minna JD, Oliver TG, Quaranta V, Sage J, et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nature Reviews. Cancer. PMID 30926931 DOI: 10.1038/S41568-019-0133-9 |
0.641 |
|
| 2019 |
Vojnic M, Kubota D, Kurzatkowski C, Offin M, Suzawa K, Benayed R, Schoenfeld AJ, Plodkowski AJ, Poirier JT, Rudin CM, Kris MG, Rosen NX, Yu HA, Riely GJ, Arcila ME, et al. Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30831205 DOI: 10.1016/J.Jtho.2018.12.038 |
0.594 |
|
| 2019 |
Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, Liggitt D, Eaton KD, Martins R, Poirier JT, Rudin CM, Milletti F, Cheng WY, Mack F, MacPherson D. Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition. Science Signaling. 12. PMID 30723171 DOI: 10.1126/Scisignal.Aau2922 |
0.67 |
|
| 2019 |
Guo H, Ci X, Ahmed M, Hua JT, Soares F, Lin D, Puca L, Vosoughi A, Xue H, Li E, Su P, Chen S, Nguyen T, Liang Y, Zhang Y, ... ... Poirier JT, et al. ONECUT2 is a driver of neuroendocrine prostate cancer. Nature Communications. 10: 278. PMID 30655535 DOI: 10.1038/S41467-018-08133-6 |
0.52 |
|
| 2019 |
Lai WV, Rizvi H, Egger JV, Plodkowski AJ, Ginsberg MS, Kris MG, Beras A, Rekhtman N, Poirier JT, Hellmann MD, Rudin CM. Real-world experience and molecular features of response to immune checkpoint blockade in patients with recurrent small cell lung cancer. Journal of Clinical Oncology. 37: 8556-8556. DOI: 10.1200/Jco.2019.37.15_Suppl.8556 |
0.541 |
|
| 2019 |
Fernandez L, Poirier J, Rodriguez A, Hulling M, Richardson R, Sutton R, Jiles R, Schonhoft J, Lee J, Ebrahim N, Carbone E, Barnett E, Landers M, Wang Y, Dittamore R, et al. Abstract 1348: Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1348 |
0.557 |
|
| 2019 |
Lok B, Laird J, Carney B, Kossatz S, De Stanchina E, Reiner T, Poirier J, Rudin C. P1.12-15 PET Imaging of [18F]PARP Inhibitor as a Pharmacodynamic Biomarker of Talazoparib in Small Cell Lung Cancer PDXs Journal of Thoracic Oncology. 14: S539-S540. DOI: 10.1016/J.Jtho.2019.08.1128 |
0.589 |
|
| 2018 |
Ruscetti M, Leibold J, Bott MJ, Fennell M, Kulick A, Salgado NR, Chen CC, Ho YJ, Sanchez-Rivera FJ, Feucht J, Baslan T, Tian S, Chen HA, Romesser PB, Poirier JT, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science (New York, N.Y.). 362: 1416-1422. PMID 30573629 DOI: 10.1126/Science.Aas9090 |
0.615 |
|
| 2018 |
Kumar D, Lisok A, Dahmane E, McCoy MD, Shelake S, Chatterjee S, Allaj V, Sysa-Shah P, Wharram B, Lesniak WG, Tully E, Gabrielson E, Jaffee EM, Poirier JT, Rudin CM, et al. Peptide-based PET quantifies target engagement of PD-L1 therapeutics. The Journal of Clinical Investigation. PMID 30457978 DOI: 10.1172/Jci122216 |
0.465 |
|
| 2018 |
Laird JH, Lok BH, Ma J, Bell A, de Stanchina E, Poirier JT, Rudin CM. Talazoparib is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29945991 DOI: 10.1158/1078-0432.Ccr-18-0401 |
0.661 |
|
| 2018 |
Sharma SK, Chow A, Monette S, Vivier D, Pourat J, Edwards KJ, Dilling TR, Abdel-Atti D, Zeglis BM, Poirier JT, Lewis JS. Fc-mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. Cancer Research. PMID 29363548 DOI: 10.1158/0008-5472.Can-17-1958 |
0.335 |
|
| 2018 |
Carney B, Kossatz S, Lok BH, Schneeberger V, Gangangari KK, Pillarsetty NVK, Weber WA, Rudin CM, Poirier JT, Reiner T. Target engagement imaging of PARP inhibitors in small-cell lung cancer. Nature Communications. 9: 176. PMID 29330466 DOI: 10.1038/S41467-017-02096-W |
0.569 |
|
| 2018 |
Sabari JK, Julian RA, Ni A, Halpenny D, Hellmann MD, Drilon AE, Li BT, Poirier JT, Rudin CM, Rekhtman N. Outcomes of advanced pulmonary large cell neuroendocrine carcinoma stratified by RB1 loss, SLFN11 expression, and tumor mutational burden. Journal of Clinical Oncology. 36: e20568-e20568. DOI: 10.1200/Jco.2018.36.15_Suppl.E20568 |
0.539 |
|
| 2018 |
Vojnic M, Kurzatkowski C, Kubota D, Suzawa K, Liu Z, Mattar M, Khodos I, Poirier JT, de Stanchina E, Rudin CM, Riely GJ, Yu HA, Arcila ME, Ladanyi M, Somwar R. Acquired BRAF fusions as a mechanism of resistance to EGFR therapy. Journal of Clinical Oncology. 36: 12122-12122. DOI: 10.1200/Jco.2018.36.15_Suppl.12122 |
0.563 |
|
| 2018 |
Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, Eaton KD, Martins R, Poirier J, Rudin CM, Milletti F, Mack F, MacPherson D. Abstract B08: Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-B08 |
0.567 |
|
| 2018 |
Jun HT, Lohrmann C, Allaj V, Scholz W, Rainey GJ, Weber WA, Lewis JS, Poirier J, Maffuid PW. Abstract A062: Using CA19-9 as a translational biomarker for sLea targeted agents MVT-5873 and MVT-1075 in cancer Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A062 |
0.413 |
|
| 2018 |
Lok B, Laird J, Ma J, De Stanchina E, Poirier J, Rudin C. MA22.01 PARP Inhibitor Radiosensitization of Small Cell Lung Cancer Differs by PARP Trapping Potency Journal of Thoracic Oncology. 13: S433. DOI: 10.1016/J.Jtho.2018.08.501 |
0.653 |
|
| 2018 |
Owonikoko T, Dahlberg S, Sica G, Poirier J, Byers L, Rudin C, Wistuba I, Ramalingam S. P3.12-06 SLFN11 Expression and Efficacy of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study Journal of Thoracic Oncology. 13: S972. DOI: 10.1016/J.Jtho.2018.08.1829 |
0.633 |
|
| 2018 |
Laird J, Lok B, Ma J, Bell A, De Stanchina E, Poirier J, Rudin C. PARP trapping by Talazoparib is a Potent Mechanism of Radiosensitization in Small Cell Lung Cancer Cell Lines and Patient-Derived Xenografts International Journal of Radiation Oncology*Biology*Physics. 102: e184-e185. DOI: 10.1016/J.Ijrobp.2018.07.676 |
0.65 |
|
| 2017 |
Poirier JT. CRISPR Libraries and Screening. Progress in Molecular Biology and Translational Science. 152: 69-82. PMID 29150005 DOI: 10.1016/Bs.Pmbts.2017.10.002 |
0.327 |
|
| 2017 |
Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Sánchez-Rivera FJ, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, ... ... Poirier JT, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nature Medicine. PMID 28967920 DOI: 10.1038/Nm.4407 |
0.646 |
|
| 2017 |
Miles LA, Burga LN, Gardner EE, Bostina M, Poirier JT, Rudin CM. Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus. The Journal of Clinical Investigation. PMID 28650343 DOI: 10.1172/Jci93472 |
0.51 |
|
| 2017 |
Sabari JK, Lok BH, Laird JH, Poirier JT, Rudin CM. Unravelling the biology of SCLC: implications for therapy. Nature Reviews. Clinical Oncology. PMID 28534531 DOI: 10.1038/Nrclinonc.2017.71 |
0.588 |
|
| 2017 |
Sharma SK, Pourat J, Abdel-Atti D, Carlin SD, Piersigilli A, Bankovich AJ, Gardner EE, Hamdy O, Isse K, Bheddah S, Sandoval J, Cunanan KM, Johansen EB, Allaj V, Sisodiya V, ... ... Poirier JT, et al. Non-invasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer. Cancer Research. PMID 28487384 DOI: 10.1158/0008-5472.Can-17-0299 |
0.617 |
|
| 2017 |
Cooper J, Xu Q, Zhou L, Pavlovic M, Ojeda V, Moulick K, de Stanchina E, Poirier JT, Zauderer M, Rudin CM, Karajannis MA, Hanemann CO, Giancotti FG. Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis. Molecular Cancer Therapeutics. PMID 28468780 DOI: 10.1158/1535-7163.Mct-16-0821 |
0.537 |
|
| 2017 |
Gardner EE, Poirier JT, Rudin CM. Histone Code Aberrancies in Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 12: 599-601. PMID 28343540 DOI: 10.1016/J.Jtho.2017.02.008 |
0.612 |
|
| 2017 |
Gardner EE, Lok BH, Schneeberger VE, Desmeules P, Miles LA, Arnold PK, Ni A, Khodos I, de Stanchina E, Nguyen T, Sage J, Campbell JE, Ribich S, Rekhtman N, Dowlati A, ... ... Poirier JT, et al. Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis. Cancer Cell. 31: 286-299. PMID 28196596 DOI: 10.1016/J.Ccell.2017.01.006 |
0.661 |
|
| 2017 |
Velcheti V, Schwartz S, Cecchi F, Tian Y, Sellappan S, Rudin C, Poirier J, Hembrough T. P1.02-001 SLFN11 Expression in Early Stage Non-Small Cell Lung Cancer Predicts Benefit from Adjuvant Chemotherapy with Taxane and Platinum Journal of Thoracic Oncology. 12: S1924-S1925. DOI: 10.1016/J.Jtho.2017.09.733 |
0.606 |
|
| 2017 |
Owonikoko T, Dahlberg S, Poirier J, Sica G, Rudin C, Ramalingam S. OA 08.06 Exploratory Analysis for Predictors of Benefit of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study Journal of Thoracic Oncology. 12: S1766-S1767. DOI: 10.1016/J.Jtho.2017.09.373 |
0.639 |
|
| 2017 |
Lok B, Laird J, Carney B, Kossatz S, Donabedian P, Shah N, Sadique A, De StanChina E, Reiner T, Poirier J, Rudin C. P3.15-008 [F18]PARPi PET as an In Vivo Pharmacodynamic Biomarker of PARP Inhibitor Therapy in Patient-Derived Xenografts of Small Cell Lung Cancer Journal of Thoracic Oncology. 12: S2340-S2341. DOI: 10.1016/J.Jtho.2017.09.1798 |
0.612 |
|
| 2017 |
Laird J, Lok B, Carney B, Kossatz S, Ma J, Bell A, Shah N, Sadique A, De Stanchina E, Reiner T, Poirier J, Rudin C. [ 18 F]PARPi PET as a Marker of Intratumoral Talazoparib Level in Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S54. DOI: 10.1016/J.Ijrobp.2017.06.136 |
0.591 |
|
| 2016 |
Rudin CM, Poirier JT. Small-cell lung cancer in 2016: Shining light on novel targets and therapies. Nature Reviews. Clinical Oncology. PMID 27958293 DOI: 10.1038/Nrclinonc.2016.203 |
0.638 |
|
| 2016 |
Lok BH, Feng Y, Gardner EE, Yu GK, Ru YK, Riaz N, deStanchina E, Powell SN, Shen YJ, Poirier JT, Rudin CM. SLFN11 Is Necessary for Single Agent Sensitivity to Talazoparib, a Potent PARP Inhibitor, But Not for Radiosensitization in Small Cell Lung Cancer (SCLC) Cell Lines and Patient-Derived Xenografts (PDX). International Journal of Radiation Oncology, Biology, Physics. 96: S75. PMID 27676009 DOI: 10.1016/J.Ijrobp.2016.06.191 |
0.65 |
|
| 2016 |
Schneeberger VE, Allaj V, Gardner EE, Poirier JT, Rudin CM. Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis. Plos One. 11: e0160587. PMID 27611664 DOI: 10.1371/Journal.Pone.0160587 |
0.598 |
|
| 2016 |
Lok BH, Gardner EE, Schneeberger VE, Ni A, Desmeules P, Rekhtman N, de Stanchina E, Teicher BA, Riaz N, Powell SN, Poirier JT, Rudin CM. PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27440269 DOI: 10.1158/1078-0432.Ccr-16-1040 |
0.664 |
|
| 2016 |
Shamay Y, Elkabets M, Li H, Shah J, Brook S, Wang F, Adler K, Baut E, Scaltriti M, Jena PV, Gardner EE, Poirier JT, Rudin CM, Baselga J, Haimovitz-Friedman A, et al. P-selectin is a nanotherapeutic delivery target in the tumor microenvironment. Science Translational Medicine. 8: 345ra87. PMID 27358497 DOI: 10.1126/Scitranslmed.Aaf7374 |
0.528 |
|
| 2016 |
Manchado E, Weissmueller S, Morris JP, Chen CC, Wullenkord R, Lujambio A, de Stanchina E, Poirier JT, Gainor JF, Corcoran RB, Engelman JA, Rudin CM, Rosen N, Lowe SW. A combinatorial strategy for treating KRAS-mutant lung cancer. Nature. PMID 27338794 DOI: 10.1038/Nature18600 |
0.662 |
|
| 2016 |
Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, Volkmer AK, Volkmer JP, Liu J, Lim JS, Yang D, Seitz G, Nguyen T, Wu D, Jude K, ... ... Poirier JT, et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. The Journal of Clinical Investigation. PMID 27294525 DOI: 10.1172/Jci81603 |
0.557 |
|
| 2016 |
Rekhtman N, Pietanza MC, Hellmann M, Naidoo J, Arora A, Won H, Halpenny DF, Wang H, Tian SK, Litvak AM, Paik PK, Drilon A, Socci N, Poirier JT, Shen R, et al. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26960398 DOI: 10.1158/1078-0432.Ccr-15-2946 |
0.558 |
|
| 2016 |
Behnam Azad B, Lisok A, Chatterjee S, Poirier JT, Pullambhatla M, Luker GD, Pomper MG, Nimmagadda S. Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912435 DOI: 10.2967/Jnumed.115.167932 |
0.477 |
|
| 2016 |
Bunn PA, Minna J, Augustyn A, Gazdar A, Ouadah Y, Krasnow MA, Berns A, Brambilla E, Rekhtman N, Massion PP, Niederst M, Peifer M, Yokota J, Govindan R, Poirier J, et al. Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes? Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26829312 DOI: 10.1016/J.Jtho.2016.01.012 |
0.623 |
|
| 2016 |
Miles LA, Poirier JT, Rudin CM. Abstract 4356: Identification of the anthrax toxin receptor (ANTXR1) as the high affinity cellular receptor for Seneca Valley Virus (SVV) Cancer Research. 76: 4356-4356. DOI: 10.1158/1538-7445.Am2016-4356 |
0.531 |
|
| 2016 |
Gardner EE, Lok BH, Schneeberger VE, Stanchina Ed, Poirier JT, Rudin CM. Abstract 4187: Loss of SLFN11 or gain of TWIST1 promote chemotherapy resistance in small cell lung cancer Cancer Research. 76: 4187-4187. DOI: 10.1158/1538-7445.Am2016-4187 |
0.508 |
|
| 2016 |
Lok BH, Feng Y, Yu GK, Gardner EE, Riaz N, Ru Y(, Stanchina Ed, Powell SN, Shen J, Poirier JT, Rudin CM. Abstract 3756: PARP inhibitor sensitivity in small cell lung cancer cell lines and patient-derived xenografts correlates with SLFN11 expression but not with structural homologous recombination deficiency Cancer Research. 76: 3756-3756. DOI: 10.1158/1538-7445.Am2016-3756 |
0.537 |
|
| 2015 |
Saunders LR, Bankovich AJ, Anderson WC, Aujay MA, Bheddah S, Black K, Desai R, Escarpe PA, Hampl J, Laysang A, Liu D, Lopez-Molina J, Milton M, Park A, Pysz MA, ... ... Poirier JT, et al. A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Science Translational Medicine. 7: 302ra136. PMID 26311731 DOI: 10.1126/Scitranslmed.Aac9459 |
0.592 |
|
| 2015 |
Miles LA, Brennen WN, Rudin CM, Poirier JT. Correction: Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for use in Peptide-Prodrug Therapy. Plos One. 10: e0136480. PMID 26287921 DOI: 10.1371/Journal.Pone.0136480 |
0.52 |
|
| 2015 |
Miles LA, Brennen WN, Rudin CM, Poirier JT. Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy. Plos One. 10: e0129103. PMID 26069962 DOI: 10.1371/journal.pone.0129103 |
0.459 |
|
| 2015 |
Niederst MJ, Sequist LV, Poirier JT, Mermel CH, Lockerman EL, Garcia AR, Katayama R, Costa C, Ross KN, Moran T, Howe E, Fulton LE, Mulvey HE, Bernardo LA, Mohamoud F, et al. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer. Nature Communications. 6: 6377. PMID 25758528 DOI: 10.1038/Ncomms7377 |
0.636 |
|
| 2015 |
Poirier JT, Gardner EE, Connis N, Moreira AL, de Stanchina E, Hann CL, Rudin CM. DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2. Oncogene. PMID 25746006 DOI: 10.1038/Onc.2015.38 |
0.599 |
|
| 2015 |
Vendetti FP, Topper M, Huang P, Dobromilskaya I, Easwaran H, Wrangle J, Baylin SB, Poirier JT, Rudin CM. Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer. Oncotarget. 6: 56-70. PMID 25474141 DOI: 10.18632/Oncotarget.2695 |
0.613 |
|
| 2015 |
Burke MJ, Ahern C, Weigel BJ, Poirier JT, Rudin CM, Chen Y, Cripe TP, Bernhardt MB, Blaney SM. Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group. Pediatric Blood & Cancer. 62: 743-50. PMID 25307519 DOI: 10.1002/Pbc.25269 |
0.461 |
|
| 2015 |
Schneeberger V, Poirier J, Rudin C. Abstract LB-286: The patient-derived xenograft mouse model dilemma; a new solution for an old problem Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-286 |
0.596 |
|
| 2015 |
Stewart PA, Li J, Fisher KJ, Dhungana S, Stewart D, Sumner S, Gardner E, Poirier J, Rudin CM, Welsh EA, Eschrich S, Chen A, Haura EB. Abstract 3752: Integrating proteomics and metabolomics characterizes active pathways and potential drug targets in small cell lung cancer Cancer Research. 75: 3752-3752. DOI: 10.1158/1538-7445.Am2015-3752 |
0.404 |
|
| 2014 |
Rudin CM, Drilon A, Poirier JT. RET mutations in neuroendocrine tumors: including small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1240-2. PMID 25122419 DOI: 10.1097/Jto.0000000000000301 |
0.687 |
|
| 2014 |
Gardner EE, Connis N, Poirier JT, Cope L, Dobromilskaya I, Gallia GL, Rudin CM, Hann CL. Rapamycin rescues ABT-737 efficacy in small cell lung cancer. Cancer Research. 74: 2846-56. PMID 24614082 DOI: 10.1158/0008-5472.Can-13-3460 |
0.625 |
|
| 2014 |
Rudin CM, Poirier JT. MYC, MAX, and small cell lung cancer. Cancer Discovery. 4: 273-4. PMID 24596200 DOI: 10.1158/2159-8290.Cd-14-0069 |
0.66 |
|
| 2014 |
Rudin C, Connis N, Hann C, Poirier J. Epigenetic Analysis of Small Cell Lung Cancer Defines Distinct Disease Subsets International Journal of Radiation Oncology*Biology*Physics. 90: S65-S66. DOI: 10.1016/J.Ijrobp.2014.08.289 |
0.644 |
|
| 2013 |
Poirier JT, Dobromilskaya I, Moriarty WF, Peacock CD, Hann CL, Rudin CM. Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer. Journal of the National Cancer Institute. 105: 1059-65. PMID 23739064 DOI: 10.1093/Jnci/Djt130 |
0.61 |
|
| 2013 |
Miles LA, Poirier JT, Rudin CM. Abstract 5675: Optimization of a Seneca Valley Virus (SVV) 3C protease substrate for virus-directed enzyme prodrug therapy. Cancer Research. 73: 5675-5675. DOI: 10.1158/1538-7445.Am2013-5675 |
0.448 |
|
| 2012 |
Poirier JT, Reddy PS, Idamakanti N, Li SS, Stump KL, Burroughs KD, Hallenbeck PL, Rudin CM. Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001. The Journal of General Virology. 93: 2606-13. PMID 22971818 DOI: 10.1099/Vir.0.046011-0 |
0.525 |
|
| 2012 |
Rudin CM, Durinck S, Stawiski EW, Poirier JT, Modrusan Z, Shames DS, Bergbower EA, Guan Y, Shin J, Guillory J, Rivers CS, Foo CK, Bhatt D, Stinson J, Gnad F, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nature Genetics. 44: 1111-6. PMID 22941189 DOI: 10.1038/Ng.2405 |
0.625 |
|
| 2012 |
Rudin C, Durinck S, Stawiski E, Poirier J, Modrusan Z, Bergbower E, Illei P, Varella-Garcia M, Minna J, Seshagiri S. 552 Comprehensive Genomic Profiling of Small Cell Lung Cancer Reveals SOX2 Amplification and MYCL1 Rearrangements European Journal of Cancer. 48: 170. DOI: 10.1016/S0959-8049(12)72349-3 |
0.598 |
|
| 2011 |
Rudin CM, Poirier JT, Senzer NN, Stephenson J, Loesch D, Burroughs KD, Reddy PS, Hann CL, Hallenbeck PL. Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 888-95. PMID 21304001 DOI: 10.1158/1078-0432.Ccr-10-1706 |
0.646 |
|
| 2010 |
Poirier JT, Brandenburg B, Sun E, Zhuang X, Rudin CM. Abstract 2592: Host dependency factors for binding and internalization of oncolytic Seneca Valley Virus Cancer Research. 70: 2592-2592. DOI: 10.1158/1538-7445.Am10-2592 |
0.414 |
|
| 2009 |
Hillion J, Wood LJ, Mukherjee M, Bhattacharya R, Di Cello F, Kowalski J, Elbahloul O, Segal J, Poirier J, Rudin CM, Dhara S, Belton A, Joseph B, Zucker S, Resar LM. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer. Molecular Cancer Research : McR. 7: 1803-12. PMID 19903768 DOI: 10.1158/1541-7786.Mcr-08-0336 |
0.628 |
|
| 2007 |
Mosley JD, Poirier JT, Seachrist DD, Landis MD, Keri RA. Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer. Molecular Cancer Therapeutics. 6: 2188-97. PMID 17699716 DOI: 10.1158/1535-7163.Mct-07-0235 |
0.43 |
|
| Show low-probability matches. |